Table 1.
The patient’s characteristics
| Mean age (years) | 53 |
| Age range (years) | 38–76 |
| Cytoreductive surgeries | |
| *PDS | 12(14%) |
| *IDS | 61 (70.9%) |
| Laparoscopic IDS | 13 (15.1%) |
| *FIGO stage | |
| IIIB | 12 (14%) |
| IIIC | 56 (65.1%) |
| IVA | 18 (20.9%) |
| Histopathology type | |
| High-grade serous ovarian cancer | 84 (97.7%) |
| Low-grade serous ovarian cancers | 00 |
| High-grade endometroid ovarian cancer | 02 (2.3%) |
| Others | 00 |
| Mean Ca 125 levels prior to cytoreduction | 532 u/mL |
| Ca 125 range | 386–3031 u/ml |
| Median study follow-up from the IP chemotherapy to first adjuvant IV chemotherapy | 21 days (range 1–42 days) |
PDS primary debulking surgery, IDS interval debulking surgery, FIGO International Federation of Obstetrics and Gynaecology, IP intraperitoneal chemotherapy, IV intravenous